Taken together, our study contributes key insights to the fast-growing, yet understudied, field of cancer metabolism and identifies CD37 as a gatekeeper of a fatty acid metabolic switch in aggressive B-cell lymphoma. This evidence concerns the gene CD37 and cancer.